TrialCirculation2017

Recurrent Hospitalization Among Patients With Atrial Fibrillation Undergoing Intracoronary Stenting Treated With 2 Treatment Strategies of Rivaroxaban or a Dose-Adjusted Oral Vitamin K Antagonist Treatment Strategy.

C Michael Gibson et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.